Breton M Asken1, Russell M Bauer2, Steven T DeKosky2, Zachary M Houck2, Charles C Moreno2, Michael S Jaffee2, Dewayne N Dubose2, Jonathan K Boone2, Arthur G Weber2, James R Clugston2. 1. From the Departments of Clinical and Health Psychology (B.M.A., R.M.B., Z.M.H., C.C.M.), Neurology (R.M.B., S.T.D., M.S.J., J.R.C.), and Community Health and Family Medicine (J.R.C.), and University Athletic Association (J.K.B., D.N.D., J.R.C.), University of Florida, Gainesville; and Banyan Biomarkers, Inc. (A.G.W.), Alachua, FL. basken8@phhp.ufl.edu. 2. From the Departments of Clinical and Health Psychology (B.M.A., R.M.B., Z.M.H., C.C.M.), Neurology (R.M.B., S.T.D., M.S.J., J.R.C.), and Community Health and Family Medicine (J.R.C.), and University Athletic Association (J.K.B., D.N.D., J.R.C.), University of Florida, Gainesville; and Banyan Biomarkers, Inc. (A.G.W.), Alachua, FL.
Abstract
OBJECTIVE: To examine the effect of concussion history and cumulative exposure to collision sports on baseline serum biomarker concentrations, as well as associations between biomarker concentrations and clinical assessments. METHODS: In this observational cohort study, β-amyloid peptide 42 (Aβ42), total tau, S100 calcium binding protein B (S100B), ubiquitin carboxy-terminal hydrolyzing enzyme L1 (UCH-L1), glial fibrillary acidic protein, microtubule associated protein 2, and 2',3'-cyclic-nucleotide 3'-phosphodiesterase serum concentrations were measured in 415 (61% male, 40% white, aged 19.0 ± 1.2 years) nonconcussed collegiate athletes without recent exposure to head impacts. Regression analyses were used to evaluate the relationship between self-reported history of concussion(s), cumulative years playing collision sports, clinical assessments, and baseline biomarker concentrations. Football-specific analyses were performed using a modified Cumulative Head Impact Index. Clinical assessments included symptom, cognitive, balance, and oculomotor tests. RESULTS: Athletes with a greater number of concussions had a higher baseline Aβ42 concentration only (ρ = 0.140, p = 0.005, small effect size). No biomarker concentrations correlated with cumulative exposure to collision sports. Race status fully mediated the correlations of S100B, UCH-L1, and Aβ42 with cognitive scores. Football exposure, specifically, was not associated with serum biomarker concentrations or clinical assessment scores based on the modified Cumulative Head Impact Index. CONCLUSION: Concussion-related serum biomarkers showed no consistent association with concussion history, cumulative exposure to collision sports, or clinical assessments in a sample of healthy collegiate athletes. Serum Aβ42 concentrations could increase following multiple previous concussions. Considering race status is essential when investigating links between biomarkers and cognition. The biomarkers studied may not detect residual effects of concussion or repetitive head impact exposure in otherwise asymptomatic collegiate athletes without recent exposure to head impacts. Much more research is needed for identifying reliable and valid blood biomarkers of brain trauma history.
OBJECTIVE: To examine the effect of concussion history and cumulative exposure to collision sports on baseline serum biomarker concentrations, as well as associations between biomarker concentrations and clinical assessments. METHODS: In this observational cohort study, β-amyloid peptide 42 (Aβ42), total tau, S100 calcium binding protein B (S100B), ubiquitin carboxy-terminal hydrolyzing enzyme L1 (UCH-L1), glial fibrillary acidic protein, microtubule associated protein 2, and 2',3'-cyclic-nucleotide 3'-phosphodiesterase serum concentrations were measured in 415 (61% male, 40% white, aged 19.0 ± 1.2 years) nonconcussed collegiate athletes without recent exposure to head impacts. Regression analyses were used to evaluate the relationship between self-reported history of concussion(s), cumulative years playing collision sports, clinical assessments, and baseline biomarker concentrations. Football-specific analyses were performed using a modified Cumulative Head Impact Index. Clinical assessments included symptom, cognitive, balance, and oculomotor tests. RESULTS: Athletes with a greater number of concussions had a higher baseline Aβ42 concentration only (ρ = 0.140, p = 0.005, small effect size). No biomarker concentrations correlated with cumulative exposure to collision sports. Race status fully mediated the correlations of S100B, UCH-L1, and Aβ42 with cognitive scores. Football exposure, specifically, was not associated with serum biomarker concentrations or clinical assessment scores based on the modified Cumulative Head Impact Index. CONCLUSION: Concussion-related serum biomarkers showed no consistent association with concussion history, cumulative exposure to collision sports, or clinical assessments in a sample of healthy collegiate athletes. Serum Aβ42 concentrations could increase following multiple previous concussions. Considering race status is essential when investigating links between biomarkers and cognition. The biomarkers studied may not detect residual effects of concussion or repetitive head impact exposure in otherwise asymptomatic collegiate athletes without recent exposure to head impacts. Much more research is needed for identifying reliable and valid blood biomarkers of brain trauma history.
Authors: Paul McCrory; Willem Meeuwisse; Jiří Dvořák; Mark Aubry; Julian Bailes; Steven Broglio; Robert C Cantu; David Cassidy; Ruben J Echemendia; Rudy J Castellani; Gavin A Davis; Richard Ellenbogen; Carolyn Emery; Lars Engebretsen; Nina Feddermann-Demont; Christopher C Giza; Kevin M Guskiewicz; Stanley Herring; Grant L Iverson; Karen M Johnston; James Kissick; Jeffrey Kutcher; John J Leddy; David Maddocks; Michael Makdissi; Geoff T Manley; Michael McCrea; William P Meehan; Shinji Nagahiro; Jon Patricios; Margot Putukian; Kathryn J Schneider; Allen Sills; Charles H Tator; Michael Turner; Pieter E Vos Journal: Br J Sports Med Date: 2017-04-26 Impact factor: 13.800
Authors: Sanna Neselius; Henrik Zetterberg; Kaj Blennow; Jeffrey Randall; David Wilson; Jan Marcusson; Helena Brisby Journal: Brain Inj Date: 2013-03-08 Impact factor: 2.311
Authors: Paul McCrory; Willem H Meeuwisse; Mark Aubry; Bob Cantu; Jirí Dvorák; Ruben J Echemendia; Lars Engebretsen; Karen Johnston; Jeffrey S Kutcher; Martin Raftery; Allen Sills; Brian W Benson; Gavin A Davis; Richard G Ellenbogen; Kevin Guskiewicz; Stanley A Herring; Grant L Iverson; Barry D Jordan; James Kissick; Michael McCrea; Andrew S McIntosh; David Maddocks; Michael Makdissi; Laura Purcell; Margot Putukian; Kathryn Schneider; Charles H Tator; Michael Turner Journal: Br J Sports Med Date: 2013-04 Impact factor: 13.800
Authors: Kathryn L O'Connor; C Dain Allred; Kenneth L Cameron; Darren E Campbell; Christopher J D'Lauro; Megan N Houston; Brian R Johnson; Tim F Kelly; Gerald McGinty; Patrick G O'Donnell; Karen Y Peck; Steven J Svoboda; Paul Pasquina; Thomas McAllister; Michael McCrea; Steven P Broglio Journal: Mil Med Date: 2018-11-01 Impact factor: 1.437
Authors: Henrik Zetterberg; Michael Jonsson; Abdullah Rasulzada; Cornel Popa; Ewa Styrud; Max Albert Hietala; Lars Rosengren; Anders Wallin; Kaj Blennow Journal: Br J Sports Med Date: 2007-05-11 Impact factor: 13.800
Authors: Anlys Olivera; Natasha Lejbman; Andreas Jeromin; Louis M French; Hyung-Suk Kim; Ann Cashion; Vincent Mysliwiec; Ramon Diaz-Arrastia; Jessica Gill Journal: JAMA Neurol Date: 2015-10 Impact factor: 18.302
Authors: Michael L Alosco; Yorghos Tripodis; Johnny Jarnagin; Christine M Baugh; Brett Martin; Christine E Chaisson; Nate Estochen; Linan Song; Robert C Cantu; Andreas Jeromin; Robert A Stern Journal: Alzheimers Dement (Amst) Date: 2016-12-10
Authors: Breton M Asken; Russell M Bauer; Steven T DeKosky; Zachary M Houck; Charles C Moreno; Michael S Jaffee; Arthur G Weber; James R Clugston Journal: Neurology Date: 2018-11-07 Impact factor: 9.910
Authors: Pashtun Shahim; Henrik Zetterberg; Joel Simrén; Nicholas J Ashton; Gina Norato; Michael Schöll; Yelverton Tegner; Ramon Diaz-Arrastia; Kaj Blennow Journal: Neurology Date: 2022-06-02 Impact factor: 11.800
Authors: Jazmin O Harrell; Jessica E Morgan; Steven D Beck; Iustin C Scobercea; Julien S Baker; Allan Knox; Jorge M Serrador; Matthew J Rogatzki Journal: Sci Rep Date: 2022-07-18 Impact factor: 4.996
Authors: Michael L Alosco; Yorghos Tripodis; Inga K Koerte; Jonathan D Jackson; Alicia S Chua; Megan Mariani; Olivia Haller; Éimear M Foley; Brett M Martin; Joseph Palmisano; Bhupinder Singh; Katie Green; Christian Lepage; Marc Muehlmann; Nikos Makris; Robert C Cantu; Alexander P Lin; Michael Coleman; Ofer Pasternak; Jesse Mez; Sylvain Bouix; Martha E Shenton; Robert A Stern Journal: Front Hum Neurosci Date: 2019-12-20 Impact factor: 3.169